SUBSCRIBE
SUBSCRIBE
Mark Deming

Mark Deming

Opinion author

Mark Deming is an intellectual property attorney at Polsinelli. His practice includes pharmaceutical and medical device patent litigation.

Photo of a judge's gavel, a balance and a stack of papers
Opinion
Recent Precedents Show Overseas Biosimilars Companies Can Be Sued in US
Findings that U.S. companies can sue foreign rivals despite limited business operations in the country could dissuade drug developers from targeting the U.S. market, potentially benefiting domestic producers of biosimilars.
June 18, 2025
 · 
3 min read
 · 
Mark Deming
OSZAR »